Cargando…
Adverse cardiac remodeling is absent in patients with true controlled resistant hypertension
Resistant hypertension (RHTN), defined as blood pressure (BP) that is uncontrolled with ≥3 medications, including a long‐acting thiazide diuretic, also includes a subset with BP that is controlled with ≥4 medications, so‐called controlled RHTN. This resistance is attributed to intravascular volume e...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10184488/ https://www.ncbi.nlm.nih.gov/pubmed/37013369 http://dx.doi.org/10.1111/jch.14625 |
_version_ | 1785042162723848192 |
---|---|
author | Matanes, Faris Siddiqui, Mohammed Velasco, Alejandro Sharifov, Oleg Kreps, Eric Dudenbostel, Tanja Judd, Eric K Zhang, Bin Lloyd, Steven G Oparil, Suzanne Calhoun, David A |
author_facet | Matanes, Faris Siddiqui, Mohammed Velasco, Alejandro Sharifov, Oleg Kreps, Eric Dudenbostel, Tanja Judd, Eric K Zhang, Bin Lloyd, Steven G Oparil, Suzanne Calhoun, David A |
author_sort | Matanes, Faris |
collection | PubMed |
description | Resistant hypertension (RHTN), defined as blood pressure (BP) that is uncontrolled with ≥3 medications, including a long‐acting thiazide diuretic, also includes a subset with BP that is controlled with ≥4 medications, so‐called controlled RHTN. This resistance is attributed to intravascular volume excess. Patients with RHTN overall have a higher prevalence of left ventricular hypertrophy (LVH) and diastolic dysfunction compared to patients with non‐RHTN. We tested the hypothesis that patients with controlled RHTN due to the intravascular volume excess have higher left ventricular mass index (LVMI), higher prevalence of LVH, larger intracardiac volumes, and more diastolic dysfunction compared to patients with controlled non‐resistant hypertension (CHTN), defined as BP controlled with ≤3 anti‐hypertensive medications. Patients with controlled RHTN (n = 69) or CHTN (n = 63) who were treated at the University of Alabama at Birmingham were offered enrollment and underwent cardiac magnetic resonance imaging. Diastolic function was assessed by peak filling rate, time needed in diastole to recover 80% of stroke volume, E:A ratios and left atrial volume. LVMI was higher in patients with controlled RHTN (64.4 ± 22.5 vs 56.9 ± 11.5; P = .017). Intracardiac volumes were similar in both groups. Diastolic function parameters were not significantly different between groups. There were no significant differences in age, gender, race, body mass index, dyslipidemia between the two groups. The findings show that patients with controlled RHTN have higher LVMI, but comparable diastolic function to those of patients with CHTN. |
format | Online Article Text |
id | pubmed-10184488 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-101844882023-05-16 Adverse cardiac remodeling is absent in patients with true controlled resistant hypertension Matanes, Faris Siddiqui, Mohammed Velasco, Alejandro Sharifov, Oleg Kreps, Eric Dudenbostel, Tanja Judd, Eric K Zhang, Bin Lloyd, Steven G Oparil, Suzanne Calhoun, David A J Clin Hypertens (Greenwich) Resistant Hypertension Resistant hypertension (RHTN), defined as blood pressure (BP) that is uncontrolled with ≥3 medications, including a long‐acting thiazide diuretic, also includes a subset with BP that is controlled with ≥4 medications, so‐called controlled RHTN. This resistance is attributed to intravascular volume excess. Patients with RHTN overall have a higher prevalence of left ventricular hypertrophy (LVH) and diastolic dysfunction compared to patients with non‐RHTN. We tested the hypothesis that patients with controlled RHTN due to the intravascular volume excess have higher left ventricular mass index (LVMI), higher prevalence of LVH, larger intracardiac volumes, and more diastolic dysfunction compared to patients with controlled non‐resistant hypertension (CHTN), defined as BP controlled with ≤3 anti‐hypertensive medications. Patients with controlled RHTN (n = 69) or CHTN (n = 63) who were treated at the University of Alabama at Birmingham were offered enrollment and underwent cardiac magnetic resonance imaging. Diastolic function was assessed by peak filling rate, time needed in diastole to recover 80% of stroke volume, E:A ratios and left atrial volume. LVMI was higher in patients with controlled RHTN (64.4 ± 22.5 vs 56.9 ± 11.5; P = .017). Intracardiac volumes were similar in both groups. Diastolic function parameters were not significantly different between groups. There were no significant differences in age, gender, race, body mass index, dyslipidemia between the two groups. The findings show that patients with controlled RHTN have higher LVMI, but comparable diastolic function to those of patients with CHTN. John Wiley and Sons Inc. 2023-04-03 /pmc/articles/PMC10184488/ /pubmed/37013369 http://dx.doi.org/10.1111/jch.14625 Text en © 2023 The Authors. The Journal of Clinical Hypertension published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Resistant Hypertension Matanes, Faris Siddiqui, Mohammed Velasco, Alejandro Sharifov, Oleg Kreps, Eric Dudenbostel, Tanja Judd, Eric K Zhang, Bin Lloyd, Steven G Oparil, Suzanne Calhoun, David A Adverse cardiac remodeling is absent in patients with true controlled resistant hypertension |
title | Adverse cardiac remodeling is absent in patients with true controlled resistant hypertension |
title_full | Adverse cardiac remodeling is absent in patients with true controlled resistant hypertension |
title_fullStr | Adverse cardiac remodeling is absent in patients with true controlled resistant hypertension |
title_full_unstemmed | Adverse cardiac remodeling is absent in patients with true controlled resistant hypertension |
title_short | Adverse cardiac remodeling is absent in patients with true controlled resistant hypertension |
title_sort | adverse cardiac remodeling is absent in patients with true controlled resistant hypertension |
topic | Resistant Hypertension |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10184488/ https://www.ncbi.nlm.nih.gov/pubmed/37013369 http://dx.doi.org/10.1111/jch.14625 |
work_keys_str_mv | AT matanesfaris adversecardiacremodelingisabsentinpatientswithtruecontrolledresistanthypertension AT siddiquimohammed adversecardiacremodelingisabsentinpatientswithtruecontrolledresistanthypertension AT velascoalejandro adversecardiacremodelingisabsentinpatientswithtruecontrolledresistanthypertension AT sharifovoleg adversecardiacremodelingisabsentinpatientswithtruecontrolledresistanthypertension AT krepseric adversecardiacremodelingisabsentinpatientswithtruecontrolledresistanthypertension AT dudenbosteltanja adversecardiacremodelingisabsentinpatientswithtruecontrolledresistanthypertension AT judderick adversecardiacremodelingisabsentinpatientswithtruecontrolledresistanthypertension AT zhangbin adversecardiacremodelingisabsentinpatientswithtruecontrolledresistanthypertension AT lloydsteveng adversecardiacremodelingisabsentinpatientswithtruecontrolledresistanthypertension AT oparilsuzanne adversecardiacremodelingisabsentinpatientswithtruecontrolledresistanthypertension AT calhoundavida adversecardiacremodelingisabsentinpatientswithtruecontrolledresistanthypertension |